http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2504779-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f83739934fdc2a7659b796aa25a36413 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_376b61a3c066fcf7e66372b8513ecc78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4928939d777b75eed4eca86d24ee35ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a690e5a0fd30d0ad5ff5a55234a53cc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cf5f975d158c8f941b4879fe89c9a4e |
| publicationDate | 2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2504779-C1 |
| titleOfInvention | Method for evaluating clinical effectiveness in ulcerative colitis |
| abstract | FIELD: medicine. n SUBSTANCE: induction standard therapeutic course is followed by determining the blood serum lactoferrin concentration, and if the derived values exceed 874.7±21.6 ng/ml, the absence of a clinical remission of ulcerative colitis is stated. n EFFECT: more accurate evaluation of the clinical effectiveness in ulcerative colitis in achieving the clinical remission following the four-week therapeutic course. n 3 ex |
| priorityDate | 2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.